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Introduction: Complementary and alternative medicine (CAM) is used for treating cyclic 
perimenstrual pain and discomfort. This critical review examines women’s reported CAM use, 
its perceived effectiveness and information relating to women’s attitudes, behaviours, 
motivations and patterns of CAM use in its treatment. Material and methods: An extensive 
search of the main medical databases EBSCO, CINAHL, Medline, AMED and SCOPUS, as well 
as additional hand searches, was conducted. Papers included were confined to those that had 
been peer-reviewed, written in English and containing original research into CAM use for cyclic 
perimenstrual pain and discomfort amongst adult women. Results: CAM, particularly herbal 
medicine, nutritional supplements and massage, is widely used for a range of cyclic 
perimenstrual pain and discomfort symptoms. A large number of CAM modalities are adopted, 
often simultaneously and with little professional oversight. Women’s assessment of efficacy of 
different CAM modalities is positive, though the majority of users are self-prescribing apparently 
without professional guidance. Although the uptake of CAM for cyclic perimenstrual pain and 
discomfort is wide-spread, little empirical data is available regarding which women are using 
CAM, their motivations for doing so and importantly the sources via which women receive 
information about CAM. Conclusions: This review highlights the extensive use of (often self-
prescribed) CAM in a number of countries to alleviate the widespread symptoms of cyclic 
perimenstrual pain and discomfort. An understanding of all health care utilisation by women 
with perimenstrual pain and discomfort is vital to help ensure safe, effective and coordinated 
health care that can lead to optimal patient outcomes. 
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Key Message:  
The prevalence of perimenstrual pain and discomfort is high worldwide however the 
predominant treatment strategies are unsupervised by professional health providers. 
Complementary and alternative medicine although frequently used has undocumented benefits 





Cyclic perimenstrual pain and discomfort (CPPD) encompasses symptom clusters that recur in 
the premenstrual or luteal phase of the menstrual cycle (known as premenstrual syndrome or 
PMS) as well as those that may continue, or begin, during menstruation itself such as 
dysmenorrhea (1). Symptoms may be predominantly physical (dysmenorrhea, headache, nausea, 
fluid retention, bloating, painful or tender breasts), affective (mental or emotional), or some 
combination of both (2), are related to cyclical hormone changes, may involve one or many 
symptoms, may vary from one cycle to the next and appear to have no single etiology (2-4).   
CPPD is widely experienced by women across cultures, at some time during their reproductive 
life, with prevalence rates of women experiencing at least one CPPD-related symptom assessed 
as between 80 - 97% (4,5). Whilst not all symptoms necessarily require treatment those women 
with moderately severe to severe symptoms, occurring in 40% (4) and between 2-10% (2,5) of 
women respectively, will probably seek help. A lack of both definitional clarity and 
understanding of underlying mechanism(s) (3) have resulted in the absence of a satisfactory 
treatment strategy (3). It is possible that attitudes to CPPD amongst different cultures affect not 
only the experience of these symptoms but also the adoption of certain treatment-seeking 
behaviours (6). Despite CPPD symptoms potentially resulting in varying levels of discomfort 
and interfering greatly with women’s ability to work and lead a normal life at times during their 
cycles, many researchers have reported that with less severe CPPD symptoms women often do 
not seek professional help (7-17).                
Current conventional treatments for CPPD include mainly hormone therapies, anti-depressants, 
analgesics and anti-inflammatory drugs, symptomatic drug regimes such as diuretics and, less 
frequently, surgical interventions such as oophorectomy (2,18,19). The variety of conventional 
treatments for CPPD, over 300 to date, range from conventional drugs through to nutritional and 
psychological approaches. All available treatments are recognised as not being wholly applicable 
or satisfactory for all women nor as necessarily providing long term solutions due to the 
unknown but likely mixed etiology of symptoms (3,19). 
Meanwhile, the use of complementary and alternative medicine (CAM) – comprising a range of 
diverse health care practices and products not traditionally associated with the medical 
curriculum or medical profession such as herbal medicine, acupuncture and massage – is high 
(20,21) , particularly amongst women (22,23). There appears to be considerable use of CAM 
amongst women with CPPD (9,10,13-15,24-30), and a growing acceptance amongst medical 
professionals of the possible suitability of some CAM modalities for their treatment particularly 
herbal medicine, supplements and acupuncture (31,32).   
Whilst there are clinical trials showing efficacy of some CAM for treating aspects of CPPD such 
as acupuncture in treating dysmenorrhea (33) and Vitex agnus-castus (Chaste tree berry) for 
PMS (34) there is a need for further efficacy research. Moreover, while initial work provides 
some baseline data on CAM use for CPPD, this topic has till now been somewhat uncoordinated 
and ad hoc (2,4). There is currently no critical or systematic overview of this sub-field of 
empirical literature, a situation made more pronounced and significant by the fact CAM use for 
CPPD raises challenges for those looking to provide and manage safe, effective care for affected 
women. There is a gap in health care providers’ knowledge as to ‘best practice’ in treatment and 
an unknown risk regarding women’s concomitant use of all therapies and the extent to which 
women fully disclose all treatments to their health carers.  
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In direct response to this identified research gap, this paper reports findings from the first critical 
review of CAM use amongst women with CPPD with a focus upon prevalence of use, those 
using CAM as well as self-perceived efficacy, motivations and information seeking behaviour of 
users.  
 
Material and methods 
In order to identify the contemporary literature reporting on CAM use for CPPD database 
searches of EBSCO, CINAHL, Medline, AMED and SCOPUS were conducted, using the 
following keywords “problem bleeding” or “abnormal uterine bleeding” or “abnormal vaginal 
bleeding” or “dysfunctional uterine bleeding” or “atypical uterine bleeding” or “inter*menstrual 
bleeding” or “excessive uterine bleeding” or “excessive vaginal bleeding” or “excessive 
menstrual bleeding” or “menstruation disorder” or “menstruation disturbance” or “irregular 
bleeding/periods” or “irregular menstrual cycles” or “irregular menses” or “prolonged menstrual 
bleeding” or “prolonged uterine bleeding” or “prolonged periods” or “severe acute uterine 
bleeding” or “severe acute vaginal bleeding” or “dysmenorrh*ea” or “menstrual dysfunction”, 
“polymenorrh*ea” or “oligomenorrh*ea” or “hypermenorrh*ea" or “menometrorrhagia”, 
“uterine/vaginal h*emorrhage” or “metrorrhagia” or “painful periods” or “menstrual pain” or 
“irregular menses” or “frequent menses” or “menorrhagia” or “heavy menstrual bleeding” or 
“abnormally long or heavy menses” or “metropathia h*emorrhagica” or “increased menstrual 
loss” or “cycle related changes” or “pre*menstrual” AND “CAM”  or  “complementary 
medicine” or “complementary therapy”  or “alternative medicine” or “alternative therapy” or 
“herbal medicine” or “herbal therapy” or “acupuncture” or “natural medicine” or “naturopathy” 
or “homeopathy” or “traditional Chinese medicine” or  “osteopathy” or “nutritional therapy” or 
“nutritional medicine” or “Ayurvedic medicine” or  “massage therapy” or “aromatherapy” or  
“chiropractic” or “Reiki” or “hypnotherapy” or “spiritual therapy” or “integrative medicine” or 
“unorthodox medicine” or “unconventional medicine” or “nutritional supplement” or “herb”. 
The search was confined to papers in English published in peer-reviewed journals and which 
reported new, empirical data regarding CAM use amongst adult female populations with any 
form of CPPD.  In line with the aim and focus of the review, manuscripts which reported results 
from clinical trials (including randomised controlled trials) or case histories as well as those 
papers constituting reviews, letters or commentaries were excluded from the search.  An 
additional hand search was undertaken in a selection of international peer-reviewed journals 
(Acta Obstetrica et Gynecologica Scandinavica, BMC Women’s Health, American Journal of 
Obstetrics and Gynecology and Journal of Clinical Nursing) which were considered leading 
journals in this area of health care to add confidence that all relevant international publications 
meeting the search inclusion criteria were identified. Finally, Google Scholar was searched 
utilising a number of keywords from the extensive list above as an additional check.  
To appraise the quality of papers identified for review, a quality scoring system based on 
previously described parameters used to assess prevalence studies of CAM use was employed 
(35). Details of quality scoring are provided in Table 1. Two authors employed the quality 
appraisal scoring system to assign a systematic, quantitative value to the studies separately, 
compared their results and resolved any discrepancies by discussion. The quality scores of 





The initial search identified 7,006 records of which 113 papers were screened and from these 44 
empirical studies met the selection criteria for inclusion in the review. Thirty-six of the included 
papers report cross-sectional studies that specifically relate to the use of CAM for CPPD 
treatment and eight other papers  relate to cross-sectional surveys reporting CAM use results 
from more general populations (including and/or beyond women) which have reported on 
women with CPPD as one of a number of many other research interests. General information 
from each of the 44 articles is presented in Table 3. 
Analyses of the extensive time period of our search (1986 to 2014) reveals the exponential 
growth in empirical research focusing upon this topic over recent years - indeed the last seven 
years has produced as many papers reporting research on women’s use of CAM for CPPD 
symptoms as all research on this topic over the previous 22 years (1986-2007). Papers included 
in this review that are specific for CAM use in CPPD were conducted in Australia (3), U.K. (4), 
U.S. (9), Ethiopia (1), New Zealand (1), South Korea (1), Hong Kong (1), Japan (2 ), Turkey (2), 
Pakistan(1), Taiwan (3), Jordan (2), Egypt (1), South Africa (1), Nigeria (1), Brazil (1), India (1) 
and one tri-nation study involving UK, US and France.  
Prevalence, patterns and applications of CAM use 
Amongst all review papers, 32 focussed specifically on CPPD symptom(s) which included CAM 
use prevalence (7-17,24-30,36-49). The CAM use timeframes surveyed were variously reported 
as current/most recent cycle (7-9,11,41,44), last three months (15,17,29), last 6 months (14), last 
12 months (10,28,37,39,48); a 5-year period (36); and ’ever use’ (8,15,24-26, 44,48). However 
as shown in Table 3, 13 of the studies reviewed, failed to specify the time frame in their 
empirical work. Excluding data for ‘ever use’, 29 studies reported prevalence of CAM use 
between 0.9-98.4 % (mean=32.8%, median = 32.0%) (7-17,27-30,36-49)  when applying the 
broadest definition of CAM including self-treatments and home remedies. By comparison CAM 
use prevalence rates for all surveys post-2008 had a mean=34.4% and median=34.3% and pre-
2008 these were mean=30.4%, median=21.0%. Reported prevalence rates for CAM ‘ever users’ 
ranged from 22.4-92.0% (mean=63.0%, median=74.0%) (8,15,24-26,44,48).  
Reported prevalence of use of vitamin/mineral supplements, including vitamin B6, ranged from 
9-34% (mean=23.1%, median=24.7%) (8,9,26,39)  in large studies (n > 499), from 4.3-62.5% 
(mean=22.2%,  median=17.0% ) current use (14,15,44,47,48)  and 34.0-92.0% “ever use” 
(15,24,44,48) in those of smaller sample size (n< 500).  Other CAM in this category reportedly 
used by PMS sufferers included Evening Primrose Oil (EPO) (8,11,15,24,44,48), calcium (39), 
magnesium (24,39) and zinc (24). 
From surveys targeting CAM use and CPPD, we grouped those reporting herbs, traditional 
medicine, Chinese herbal medicine (CHM) or traditional Chinese medicine (TCM) together as 
herbal medicine. In large sample-sized studies, prevalence of use ranged between 0.5-69.7% 
(mean= 31.1%, median=35.0%) (10,25-28,36,38,39,41) and in small sample studies from 7.0-
37.3% (mean=20.6%, median=20.7%) (14,16,29,30,43-45,47). User-prevalence for CHM/TCM 
had mean and median values of 28.8% and 22.4% respectively (14,25,27-29,36,41).  Herbs 
identified were Si-Wu-Tang (41), Zhong-Jing Tang (41), Dang-Qui-Shao-Ya-San (28,36,50), St. 
John’s wort (39,44), ginger (28,41) and cinnamon (47). Herbal medicine may be part of 
treatment described as hot drinks/tea and home remedies but were not included in our herbal 
medicine calculations.  
Other CAM modalities reported for CPPD use in reviewed papers (not all with prevalence of use 
data) were homeopathy (range 0.9-14%) (12,27,38,44) , acupuncture (range 0.1-31.0%) 
(8,26,27,43,44), massage (range 1.4-61.0%) (9,13,15,16,27,39,42,43,47), mind/body therapies 
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e.g. yoga and meditation (range 0-9.5%) (8,9,27,39,44), aromatherapy (44), special/hot 
drinks/tea/coffee (10,13,14,47), faith healing (8) and Ayurvedic medicine (17). 
CAM practitioners in countries where conventional medicine predominates were consulted by 
4.0-12% of women in reviewed surveys (8,15,46) and a 2002 U.S. study reported premenstrual 
dysphoric disorder sufferers were more likely to consult CAM practitioners than those with less 
severe PMS (51). However, the 1991 PMS U.K. survey found 22.0% of women consulted both 
medical and “non-medical” providers (8) and 7.1% of Taiwanese women recorded 
simultaneously using conventional and CAM for CPPD (41). 
Two PMS surveys of ‘ever use’ reported that at least 20% of respondents had tried five or more 
treatments (15,46) and attendees at PMS clinics recorded they had tried one to 12 CAM 
(mean=3.2) (44)  and a median of four self-help remedies (including CAM) (24). Meanwhile, a 
comparative survey across the U.S., U.K. and France, of all non-prescription medicines used 
(CAM and non-CAM) to treat PMS reported only U.K. women mentioned CAM (11). In four 
population-based studies examining broad CAM use (beyond CPPD) and included in the review, 
irregular bleeding and dysmenorrhea are identified as among the five most common reasons for 
CAM use (36,50,52,53).  
The reviewed literature identified various CPPD symptoms in which women used CAM. As 
shown in Table 3 two papers specifically surveyed general CPPD and CAM, most of those 
remaining referred to dysmenorrhea and PMS. Of all reviewed papers 21, (see Table 3), 
represent data from countries retaining a strong culture/reliance on traditional medicine. Papers 
surveying dysmenorrhea included six small studies (n=23-616) with age range 16 – 28 years 
(12,14,16,28,30,55) , the remaining seven spanned menarche-55 years of age 
(7,25,29,36,38,41,42) of which all but one was based on sample sizes of 500 or more (n= 274-
23118). In the very large sample of dysmenorrheic, Taiwanese women 53.4% used mostly 
practitioner-prescribed CHM (36). However, a Japanese prospective study noted CAM was used 
equally by all women whether or not they experienced dysmenorrhea (7).  Chia et al. (2013) 
found pain in the middle of menstruation increased the likelihood that young Hong Kong women 
would resort to ‘non-pharmacological’ self-treatments than if pain occurred premenstrually or at 
either end of the period (14). 
 
CAM treatment of PMS was reported in fifteen reviewed papers, three failed to define symptoms 
(24,44,46), and the remaining surveys, (see Table 3), referred to both affective and physical 
symptoms. Age ranges for the majority of these surveys, irrespective of sample size, fell between 
18-43 years (range 15–64 years). Data collected by Gold et al. suggested women with physical 
PMS symptoms were more likely to use CAM than not (37). However, two studies surveying 
premenstrual dysphoric disorder sufferers reported these women’s higher use of CAM therapies 
(39) and visits to CAM practitioners (51) compared to those with milder PMS symptoms.  
Additionally our review identified papers in which CAM use was associated with endometriosis 
(29,49) and its associated leg pain (43);  pelvic problems (pain, pressure and dysfunctional 
uterine bleeding) (26), fibroids (29,40,45,58), menstrual problems including irregular cycles in 
younger women (17), menorrhagia (59) and mastalgia (mostly, but not exclusively, cyclical) 
(10). With increased symptom severity, women’s reported use of medication, including CAM 
increased (14,15,38,39). Tariq et al. (2009) found CAM use was more likely if symptoms 
resulted in prolonged time off work (38) and greater symptom frequency in Cheng and Lin’s 
sample increased CAM use (28). Meanwhile newer patients attending a conventional PMS clinic 
in the U.K. continued CAM use but after more than five years attendance were likely to cease its 
regular use (44).  
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Data is scant and inconsistent in the reviewed papers, regarding age, CAM use and CPPD. From 
the large Taiwanese database women aged 21-30 years were more likely to use TCM than older 
or younger age groups (36) but the survey of 15-39 year old South Korean women suggested age 
was irrelevant with just over 20% of all women choosing to use CHM (25). In the U.S., Sternfeld 
et al. (2002) reported, CAM use was higher amongst older women with PMS (39) but for women 
with fibroids younger women were greater CAM users according to Borah et al. (40). Age did 
not determine how many CAM therapies women attending a PMS clinic reported trying (44).  
Further reported profile details of women using CAM for CPPD was limited in reviewed papers, 
providing only brief information with regards to ethnicity, lifestyle factors, socio-economic and 
health status. The Taiwanese dysmenorrhea study by Pan et al. (2014) of 23,118 women found 
CAM use was higher amongst lower income women (36). Of 12 tertiary students studies 
(majority aged 18-30 years) into medication in CPPD, three indicated CAM (including non-
pharmacological treatments) were those most used (10,14,41), eight indicated that they were 
amongst those most commonly used (13,16,17,28,30,38,42,47)  with only the 1991 South Africa 
survey reporting very low CAM usage (12). Race/ethnic-specific data was limited to U.S. 
surveys where the highest CAM use for CPPD was found amongst white women (37,39,58). 
Sternfeld et al. (2002) in U.S. reported CAM use for PMS was associated with women having a 
comorbidity and those who undertook regular, exertional exercise (39) whilst Australian research 
identified non-vegetarians who experienced lower levels of CPPD were also less likely than 
vegetarians and semi-vegetarians to have consulted a CAM practitioner (60).  
Self Perceived Efficacy, Risk and Safety 
There was variation of reported efficacy measured across different CAM modalities within 
studies but maximum self-perceived efficacy ratings (including registering effectiveness, 
satisfaction or improvement) for CAM in treating CPPD symptoms were generally high. Ratings 
reported were 33% -97% for PMS sufferers (8,9,24,27,44,48), 93-99% for dysmenorrhea (14,28)  
, 79% for endometriosis (43)  and 27.7% for pelvic discomfort (26). However the reported 
number of side-effects experienced or symptom-worsening which women associated with CAM 
use was considerably less than for conventional medicine (24,26). Dissatisfaction with or finding 
CAM ‘unhelpful’, ranged from 14-69% where reported (8,44,48).  Meanwhile, women’s rating 
of CAM practitioners were limited to two PMS-focused studies where of those women who 
consulted a particular modality the recorded maximum satisfaction was 74.6% with regards to 
homeopaths (8) and 50% for osteopaths (46). 
In each of a number of studies reviewed, over 50% of participating women with CPPD believed 
their use of CAM  was satisfactory or very satisfactory specifically for vitamins/supplements for 
pelvic discomfort (26), dysmenorrhea (14) and PMS (9,15,44) (vitamin B6 especially for 
affective symptoms (9)); herbs for pelvic discomfort (26) and dysmenorrhea (14,28); 
acupuncture for pelvic discomfort (26), PMS (44) and endometriosis leg-pain (43); homeopathy 
for PMS (27,44); mind-body/yoga for PMS (9,27); and massage for endometriosis leg-pain (43) 
and PMS (9,15). A New Zealand survey reported that the severity of symptoms did not appear to 
influence PMS sufferers’ perceived treatment efficacy regarding their CAM use (9).   
In the U.S. study on treating pelvic problems, Kupperman et al. (2007) found women with a 
lower income and educational status and those of African-American origin reported greater 
satisfaction levels, than either white or Asian women, for CAM and that self-rated satisfaction 
increased with the fewer conventional medicines and more CAM treatments used, the more 
effectively symptoms resolved, and with better mental well-being (26). Within a focus group 
conducted in Australia, participants felt CAM’s effectiveness for endometriosis ranged from 
helping temporarily to providing a “radical improvement” (49). 
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Communication and information seeking of CAM users 
Detailed information/advice about CAM use for PMS as reported by Domoney et al. (2003) 
came from a number of sources including friends and/or family, media, internet and medical 
personnel (44). Interestingly, 29% of women in this study reported their CAM information as 
sourced from medical practitioners (44). The focus group consisting of 16 to 19 year-old 
Taiwanese women from Kaohsiung who used self-care strategies to manage dysmenorrhea 
indicated their mothers’ directed their use of Chinese herbs to correct energy deficiencies, 
“regulate the uterus” and “cleanse the body” (55). 
 
Motivations for using/not using CAM 
Whilst motivation for not using conventional medicine to treat CPPD symptoms was indicated in 
eight studies included in the review (11,16,29,40,45,49,54,59), none reported on women’s 
reasons for choosing CAM. Four focus group studies, two from Australia and one each from UK 
and Taiwan, canvassed the experiences and thoughts of women across a range of ages and 
mainly suffering one aspect of CPPD to provide more detailed attitudinal data for CAM use in 
their treatment (49,54,55,59).  Motivations for using CAM expressed by participants of an 
Australian focus group where 60 of 61 had adopted CAM in treating endometriosis were to 
enable them to gain control of their situation, be drug free, avoid surgery and ‘get off the medical 
roundabout’ (49). Cost was however cited as a difficulty by this group in using CAM (49). 
Whilst the other Australian focus group of sixteen 30-50 year old women with menstrual 
problems expressed “widespread acceptance of alternative natural remedies”, taking pills “for 
pain relief weren’t the only answer” and a preference for a “natural remedy” (54). Some 




This article provides the first review of international studies of CAM use by women with CPPD 
problems. The analyses of the last 29 years of empirical study on this topic reveals a number of 
significant findings that impact on and have implications for future practice and policy.  
Data from 14 out of 21 (9-17,25,27,28,30,37-39,41,42,46-48) of our reviewed papers, 
irrespective of cultural background, recorded prevalence rates of CPPD of 80% or more, 
supporting its very high prevalence generally reported in the literature (1,4,5). Variation in these 
rates is likely to be exacerbated by the lack of consistent definitions and questioning regarding 
frequency and severity of symptoms. There are many general studies of CAM use confirming its 
uptake has increased throughout the world, especially amongst women (22,23). That this 
increase can be related also to the treatment of CPPD in high income countries, is supported by 
the fall, in both the US and UK, of medical prescriptions for CPPD identified in the 1990s 
(18,19).  Indeed as far back as 2002, Wyatt et al., reported the unexpected prescription-rate drop 
even as there was increasing acceptance of PMS in the UK, leading them to speculate this may 
be because women increasingly turned to CAM (19). The fact that in our review the last seven 
years has seen as much study into this subject as was reported in previous decades tends to add 
support to this interpretation. However, since 2008 interest in CAM for CPPD has largely been 
explored in countries where traditional medicine practices have been maintained, the majority of 
the recent surveys (18 out of 21) having been conducted in African, Far and Middle Eastern 
countries. We nonetheless found studies supporting CAM use in Western countries where “ever 
use” of CAM by women with PMS shows high user prevalence of 74%-92%.  
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Whilst reported strategies in the review papers reflect some cultural nuances they show 
considerable use is being made of CAM to treat CPPD problems.  Not only are a large range of 
CAM treatments used, but multiple CAM appear to be used concurrently (8-10,14-
17,24,26,28,41,43,44,46-48,57).  Possible explanations for increasing adoption of CAM are 
suggested by focus group members who emphasised preferences for ‘natural’ treatments and to 
help them wrest back control of their own health. The investigation into increased CAM use 
remains woefully unexplored, but much needed, to ensure its safe and effective use in the future. 
The established high need for effective treatment coupled with a lack of reliable current 
information highlights the difficulty for informed guidance in future health policy and practice 
worldwide in treating CPPD.  
Our review also provides good evidence that a large proportion of women with CPPD choose not 
to consult any health professional for help.  Lack of consultation has been noted by other 
authors, with suggested reasons ranging from not wishing to ‘medicalise’ a natural process, 
acceptance of CPPD as ‘normal’ or because of the perception of ineffective available 
treatments(1,3,18,19). Therefore, it is extremely likely there will continue to be increasing use of 
CAM for CPPD through self-prescription. The motivation for not seeking professional CAM 
help remains unexplored but higher levels of self-prescribed CAM compared to professional 
CAM consultation is not new (22,61) and may be an economic measure or the perception that 
CAM is natural and therefore safe (57). Indeed reviewed studies reported that from a third to 
more than 90% of participating woman rated CAM effective in treating many symptoms, with 
few reporting adverse effects from CAM use. Self-prescription of CAM and conventional 
medicine for CPPD appears widespread, probably reflecting not only symptom prevalence 
throughout women’s reproductive lives, but also lack of effective treatment. Additionally there 
are reports of a relatively high placebo effect, from 10-50%, across both conventional and CAM 
treatments for CPPD (1,3,9,19), leading to uncertainty regarding general efficacy. This situation 
should raise concerns for healthcare providers across the board regarding both efficacy and 
safety and because concomitant use of conventional medicine and CAM has potential for adverse 
interactions but is often undisclosed to health professionals (35,52,56). 
 
The reviewed papers clearly show that women use CAM to treat a wide range of CPPD 
symptoms from the most common dysmenorrhea and PMS to premenstrual dysphoric disorder, 
fibroids, mastalgia, pelvic discomfort and endometriosis, with lower prevalence. However the 
level of CPPD symptoms and adopted treatments, other than PMS, has not been well explored in 
large samples of women below the age of 28 years. Our data whilst suggesting that CAM 
modalities are differentially preferred for particular aspects of CPPD is less clear if this is related 
to efficacy or simply reflects their official endorsement by medical practitioners amongst others. 
Difficulties arise when comparing findings from the reviewed papers with reported studies 
varying greatly in sampling methodology (convenience, self-selection, random), sources (half 
arose from tertiary and conventional medical settings) and quality of survey instruments, only 
some of which were pre-tested and/or validated. Prevalence calculations of CAM use were made 
from varying baselines - whole mixed gender populations/women in selected age range/only 
women with CPPD of survey’s interest. Levels of recall bias are likely to vary – five reviewed 
studies were prospective (7,16,39,42,51)  compared  to 39 which were retrospective 
questionnaires. In addition where supplied there was considerable variation in response rates 
(11%-100%), time frames for measuring CAM usage (last monthly cycle – ever) and detail of 
CAM lists, if supplied, which would alter levels of data capture. Indeed CAM was unspecified in 
28 out of 45 of these studies. Finally as most reviewed papers did not include geographical 
location data the extent to which differential access to CAM therapies, particularly in rural 
communities, may have altered measured prevalence of CAM use is unknown. Importantly 
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prevalence of total CAM use for CPPD is likely understated by our data as this was reported on 
individual modalities/treatments and many surveys reported women using more than one CAM 
entity. On the other hand the broad interpretation of CAM to include home remedies may have 
led to some overstatement of user prevalence.  
An important limitation of this review is that only English language papers were included. In 
addition, the inclusion of papers over this long time frame, whilst highlighting changing trends in 
CAM use for women with CPPD, makes comparisons difficult as attitudes, acceptance and scope 
of CAM has changed markedly over the last three decades. Nevertheless, the papers reviewed do 
provide important confirmation of the substantial use of different CAM for a variety of CPPD 
and that CAM attracts high levels of perceived efficacy amongst users with CPPD.  Review of 
the contemporary empirical literature also highlights the dearth of knowledge around a number 
of issues relating to CPPD and CAM use. Indeed, future empirical study is needed to help 
investigate the CPPD issues for which women are using particular CAM, the profile of these 
women, reasons for their CAM choice and whether indeed the CAM has been a beneficial 
treatment. The simultaneous use of conventional medicine and CAM raises unknown safety 
concerns regarding interactions and adverse reactions (62) generally and is unexplored for this 
group of women. Arising from the practice of self-prescribing CAM are issues of suitability, 
levels for safe and/or effective dosage and treatment duration. Past concern over potential 
neurotoxicity with high-dose vitamin B6 (19) should serve as a reminder that although CAM is 
natural with misuse it has the potential to cause harm. Finally, although cross-sectional studies 
may indicate prevalence of CPPD and CAM use they do not unequivocally establish causality. 
Clear, safe, reliable information on effective treatments, and most importantly the profile of 
users, would help inform both providers and women with CPPD towards evidence-based, 
coordinated care and treatment choices.  
Conclusion 
CPPD problems are widespread and treatment is likely to be either poor and/or professionally 
unsupervised. To contribute to more effective strategies to remedy this situation large-scale, 
national studies, including prospective, placebo-controlled studies on women with similar CPPD 
symptoms are much needed to determine CAM efficacy and safety. Further, future studies are 
also required, which  addresses the characteristics of women who choose to use CAM, their 
motivation for doing so and their reasons for preferring self-treatment It is important for health 
providers at all levels to have a solid evidence base for prescribing treatments for CPPD and this 
requires the provision of good quality, reliable data. 
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Table 1. Description of quality scoring system for the Complementary and Alternative Medicine 
(CAM) surveys reviewed. 
 
Dimensions of Quality Assessment Points Awardeda 
Methodolgy 
 A. Representative sampling strategy     1 
 B. Sample size >500       1 
 C. Response rate > 75%      1 
 D. Low recall bias – prospective or retrospective   1 
    data collection within the past 12months 
Reporting of participants’ characteristics 
 E. Status of CPPD assessed      1 
 F. Age         1 
 G. Ethnicity        1 
 H. Indicator of socio-economic status    1 
     (e.g. income, education) 
Reporting of CAM use 
 I. Definition of CAM or modalities provided to participants  1 
 J. Participants can name CAM therapies/modalities   1 
   used (open question)   
 K. Use of CAM modalities assessed     1 
 
Data adapted from Adams et al. (35). 
a Maximum score is 11 points.  
Quality of studies was assessed  based on representativeness of women in the sample through methodology and 
participant characteristics (A,B,C,D,F,G,H) validity of diagnosis to assess CPPD (E) and CAM use (I,J,K). CAM, 
complementary and alternative medicine; CPPD, cyclic perimenstrual pain and discomfort.
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Table 2. Quality assessment of reviewed articles. 
 
CAM, complementary and alternative medicine; CPPD, cyclic perimenstrual pain and discomfort; SES, Socioeconomic status.































  1. Kupperman (26) 1 1 1 1 1 1 1 1 0 0 1 9 
  2. Sternfeld (39) 1 1 0 1 1 1 1 1 1 0 1 9 
  3. Pan (36) 1 1 1 1 1 1 1 1 0 0 1 9 
  4. Hsieh (50) 1 1 1 2 1 1 0 0 1 0 1 9 
  5. Kronenberg (58) 1 1 1 1 0 1 1 1 1 0 1 9 
  6. Gold (37) 1 1 1 1 0 1 1 1 1 0 0 8 
  7. Ohde (7) 1 1 1 1 1 1 0 1 1 0 0 8 
  8. Chawla (51) 1 1 1 1 1 1 1 1 0 0 0 8 
  9. Singh (27) 1 1 0 0 0 1 1 0 1 1 1 7 
10. Cheng (41) 0 1 1 1 1 1 0 0 1 0 1 7 
11. Cheng & Lin (28) 0 1 1 1 1 1 0 0 1 0 1 7 
12. Hylan (11) 1 1 0 1 1 1 0 1 0 1 0 7 
13. Kraemer (48) 0 0 0 1 1 1 1 1 0 1 1 7 
14. Baines (60) 1 1 1 1 0 1 0 1 1 0 0 7 
15. Awad (53) 1 1 1 0 0 1 0 1 0 1 1 7 
16. Campbell (15) 0 0 0 1 1 1 0 1 1 0 1 6 
17. Pullon (9) 0 1 1 1 0 0 0 1 1 0 1 6 
18. Corney (8) 0 1 0 1 1 1 0 1 0 0 1 6 
19. Borah (40) 1 1 0 0 1 1 1 1 0 0 0 6 
20. Tariq (38) 0 1 0 0 1 1 0 1 0 1 1 6 
21. Tanaka (29) 0 0 0 1 1 1 0 1 1 0 1 6 
22. Hamaideh (47) 0 0 0 0 1 1 0 1 1 1 1 6 
23. Critchley (56) 0 0 0 1 0 1 1 1 1 1 0 6 
24. Lee (25) 1 1 0 0 0 1 0 0 0 1 1 5 
25. Chia (14) 0 0 1 1 0 1 0 0 1 0 1 5 
26. Eladawi (10) 0 1 1 1 1 1 0 0 0 0 0 5 
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27. Cronje (12) 0 0 1 0 0 1 1 0 0 1 1 5 
28. Adegbesan 
(45) 
0 0 0 0 1 1 0 1 0 1 1 5 
29. Seven (16) 0 0 1 0 1 1 0 0 0 1 1 5 
30. Sharma (17) 0 0 1 1 1 1 0 0 0 1 0 5 
31. Cox (49) 1 0 1 0 1 1 0 0 0 1 0 5 
32. Nicholson 
(61) 
0 1 1 0 0 1 1 0 0 1 0 5 
33. Tolossa (13) 0 0 1 0 1 1 0 0 0 0 1 4 
34. Missmer (43) 0 0 0 0 1 1 1 0 0 0 1 4 
35. Leather (24) 0 0 0 0 1 1 0 0 0 1 1 4 
36. Brito (42) 0 1 0 0 0 1 0 0 0 1 1 4 
37. Sawalha (52) 0 1 1 0 0 1 0 0 0 1 0 4 
38. Byles (54) 1 0 1 0 0 1 0 0 0 1 0 4 
39. AlBraik (57) 0 0 0 1 0 1 0 1 0 0 1 4 
40. Chapple (59) 0 0 0 0 0 1 1 1 0 1 0 4 
41. Domoney 
(44) 
0 0 0 0 1 1 0 0 0 0 1 3 
42. Abdul-
Razzaq (30) 
0 0 0 0 0 1 0 0 1 0 1 3 
43. Brown (46) 0 0 0 0 0 1 0 0 0 1 1 3 























CAM Therapies used/  
List supplied?  
Sample size/  
Age range 
CAM Time 











SCQ   
Multiple GP clinics 
Ever - 34% 
3 mo -21%  
Whole sample 




Ever and last 3 
months 
Unspecified 
Premenstrual Syndrome  
– 
physical and affective 
Yes 
2. Domoney (44) 






1 site- PMS clinic 
Ever – 91% 
Current–35% 
Sufferers 
Supplements, herbs, EPO 
acupuncture, homeopathy,  
Unspecified 
100  
 25 –54y 
Ever and current 
Unspecified 
Premenstrual Syndrome - 
 unspecified  
GP referred 






Commercial database  
(telephone) 
1.5% 






 21 – 64y 
Unspecified 
Unspecified 
Premenstrual Syndrome – 
physical and affective 
Unspecified 
 





Tertiary students, 1 
site 
7.5% 
 Whole sample 
Hot drinks, massage 
Unspecified 
173 
 18 – 25y 
Unspecified 
Unspecified 
Premenstrual Syndrome – 
physical and affective 
Yes 
5. Pullon (9) 




Multiple GP clinics 
33% 
Sufferers 
Massage, yoga, vitamin B6 
Yes 
1456  
 15 – 54y 
Last  cycle 
Yes 
Premenstrual Syndrome – 
physical and affective 
Unspecified 









Chinese herbal medicine 
Yes- limited  
500 
 15- 39y 





7. Corney (8)  
 U.K. 
1991 
68 - 77% 
SCQ  
Response to advert in 
two written  media 
Ever – 74% 
Last month -9% 
Sufferers 
Vitamins, homeopathic, EPO 
Unspecified 
658  
 16 – 45y 
Ever and last 
month 
Unspecified 
Premenstrual Syndrome – 
 physical and affective 
Yes 
















Endometriosis leg pain 
Yes 








Acupuncture, herbs, dietary 
supplements 
 Yes - limited  
1493 
 31 – 54y 
 Current or prior  
(Ever use) 
Unspecified 
Pelvic problems –physical 



















CAM Therapies used/  
List supplied?  
Sample size/  
Age range 
CAM Time 






10. Chia (14) 









Dietary supplements, TCM 
Yes 
240 
 18 -22y 














massage, mind-body, herbs 
Yes – limited? 
1194  
 21 – 45y 
Last 12 months 
Unspecified 
Premenstrual Syndrome – 
physical and affective 
Yes 





























 42 – 52y 
Last 12 months 
Unspecified 
Premenstrual Syndrome –
physical and affective 
Unspecified 




Prospective CPPD  




Yes - limited 
823 










SCQ & Interviewer 
Multiple sites – 























Herbs ( supplement-users 
excluded)  
? limited if yes 
127 











1 site- nursing students 
69.7% 
Treatment users 
TCM, herb tea 
Yes 
2758  




Yes (by author) 






2 sites - tertiary 
students 
35% freq Sx 
23.9%* all Sx 
Sufferers 
TCM, herb tea 
Yes 
616  
 18 – 28y 







































CAM Therapies used/  
List supplied?  
Sample size/  
Age range 
CAM Time 











1 site - tertiary students 
43.7% 
Sufferers 
Hot drinks, herbs, massage 
Unspecified 
797 

















15 – 49y 
Last 3 months 
No 
Dysmenorrhea, fibroids, 
PMS -physical & 
affective, endometriosis 
Yes 
22. Cronje (12) 















23. Leather (24) 




1 site - PMS clinic 
92% 
Sufferers 
Vit. B6, EPO, zinc,magnesium 
Unspecified 
100 










2 sites - hospital clinics 
37.3% 
Sufferers 
Herbs, cod liver oil 
Unspecified 
300 
































Non-prescription medicines  
included EPO & OTC drugs 
Unspecified 
1045 
18 – 49y 
Current 
Unspecified 
Premenstrual Syndrome - 
physical and affective 
Yes 





Recipients of pharmacy 
newsletter 
Ever -91.4 
Last yr -62.5% 
Sufferers  
Vitamin/mineral 
Vitamins, minerals, EPO 
Unspecified 
220 
26 – 56y 
Ever and Last 12 
months 
Unspecified 
Premenstrual Syndrome - 
physical and affective 
Yes 














18 – 43y 
Unspecified 
No 















 hot fluids? 
Yes 
254 
18 – 45y 
Unspecified  - 
“usually used” 
Yes 























CAM Therapies used/  
List supplied?  
Sample size/  
Age range 
CAM Time frame 










SCQ Prospective CPPD 




Massage, herb tea 
Unspecified 
371 











1 site- tertiary students 




17 – 23y 
Last 3 months 
Unspecified 
Cyclic Perimenstrual 
Pain and Discomfort 
No 













21 - 45y 
Last 12 months 
Practitioner 
Premenstrual  Syndrome 
and PMDD – physical 
and affective 
Yes 





















1 site- tertiary students 
33.9% 




17 – 24 y  
Unspecified 
Yes 









1 hospital site 
 
38.1% 
 ED patients  


























14 – 96 y 
Last 12 months 
Mixed 
General and gynecology  
Included fibroids 
No 





Survey sample of 
sufferers from 1 state 
N/A 
Sufferers 
General alternative medicine 
Unspecified 
31 




Pain and Discomfort 
Unspecified 









Alternative health practitioner 
Unspecified 
9113 
22 - 27 y 
Last 12 months 
No 
Premenstrual syndrome, 

















CAM Therapies used/  
List supplied?  
Sample size/  
Age range 
CAM Time frame 










1 site –Medical school 
N/A 
Sufferers 
Various CAM therapies 
Unspecified 
23 





40. AlBraik (57) 





Interviewer and SCQ 





Herbal medicine ever 
Herbal medicine current 
Herbal practitioner ever 
Unspecified 
330 
15 – 55+ y 
Last 6 months and 
current 
Mixed 
General health issues 
included dysmenorrhea 
No 












20 – 60+ y 
Last 2 months 
Yes 















Chinese  Medicine 
Yes 
166929 
0 – 76+ y 
Last 12 months 
No 










Local interest groups 
with snowball sampling 
10%? 
Sufferers 
EPO and homeopathy 
Unspecified 
30 














Commercial  database 
64.4% 
All women  
Variety of CAMs and CAM 
practitioner used  
Yes 
3068 
18 – 50+ y 








N/A – Not Available ; SCQ – Self-completed Questionnaire; EPO- Evening Primrose Oil; *Calculated;  ᵻStrong cultural/reliance on traditional medicine; GP – General Practitioner; HMO –
 Health Maintenance Organization ; Sx – Symptoms ; OTC – Over the Counter; ED – Emergency Department; PMS, premenstrual syndrome; GP, general practitioner; N/A, Not Available; 





                                                          
 
